// App-Quantinova.ai

6672 : Apremilast: a Potential Treatment for Dermatomyositis.

Researchers

Presenter

  • Carole Bitar

Principal Investigators

  • Hoang Ho-Pham

  • Jalal Maghfour

  • Erin Boh

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • Creatinine

  • T helper 2

  • Type 1 T helper

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Mycophenolic acid

  • Oraprine

  • chlorambucil

  • Methotrexate

  • Apremilast

  • Infliximab

  • Prednisone

  • Tacrolimus

  • Adenosine

  • Adenosine Intravenous

  • Acitretine

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved